Weighted Average Number of Shares Outstanding, Diluted of IVERIC bio, Inc. from 30 Sep 2013 to 31 Mar 2023

Taxonomy & unit: us-gaap: shares
Description: The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary: IVERIC bio, Inc. quarterly and annual Weighted Average Number of Shares Outstanding, Diluted in shares history and change rate from 30 Sep 2013 to 31 Mar 2023.
IVERIC bio, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 31 Mar 2023 was 137,087,000, a 15% increase year-over-year.
IVERIC bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 121,037,000, a 19% increase from 2021.
IVERIC bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 101,866,000, a 37% increase from 2020.
IVERIC bio, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 74,185,000, a 76% increase from 2019.
Source SEC data: View on sec.gov

Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)

Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)

Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

IVERIC bio, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023	137,087,000	+18,332,000	+15%	01 Jan 2023	31 Mar 2023	10-Q	10 May 2023	2023	Q1
Q4 2022	121,037,000	+19,171,000	+19%	01 Oct 2022	31 Dec 2022	10-K	01 Mar 2023	2022	FY
Q3 2022	120,277,000	+15,060,000	+14%	01 Jul 2022	30 Sep 2022	10-Q	04 Nov 2022	2022	Q3
Q2 2022	119,687,000	+26,278,000	+28%	01 Apr 2022	30 Jun 2022	10-Q	26 Jul 2022	2022	Q2
Q1 2022	118,755,000	+25,444,000	+27%	01 Jan 2022	31 Mar 2022	10-Q	10 May 2023	2023	Q1
Q4 2021	101,866,000			01 Oct 2021	31 Dec 2021	10-K	01 Mar 2023	2022	FY
Q3 2021	105,217,000	+12,542,000	+14%	01 Jul 2021	30 Sep 2021	10-Q	04 Nov 2022	2022	Q3
Q2 2021	93,409,000	+35,988,000	+63%	01 Apr 2021	30 Jun 2021	10-Q	26 Jul 2022	2022	Q2
Q1 2021	93,311,000			01 Jan 2021	31 Mar 2021	10-Q	04 May 2022	2022	Q1
Q3 2020	92,675,000			01 Jul 2020	30 Sep 2020	10-Q	09 Nov 2021	2021	Q3
Q2 2020	57,421,000			01 Apr 2020	30 Jun 2020	10-Q	04 Aug 2021	2021	Q2
Q3 2018	36,202,000	+155,000	+0.43%	01 Jul 2018	30 Sep 2018	10-Q	02 Nov 2018	2018	Q3
Q3 2017	36,047,000	+453,000	+1.3%	01 Jul 2017	30 Sep 2017	10-Q	02 Nov 2018	2018	Q3
Q3 2016	35,594,000	+812,000	+2.3%	01 Jul 2016	30 Sep 2016	10-Q	08 Nov 2017	2017	Q3
Q1 2016	35,256,000	+17,000	+0.05%	01 Jan 2016	31 Mar 2016	10-Q	09 May 2016	2016	Q1
Q3 2015	34,782,000	-77,000	-0.22%	01 Jul 2015	30 Sep 2015	10-Q	05 Nov 2015	2015	Q3
Q1 2015	35,239,000	+2,957,000	+9.2%	01 Jan 2015	31 Mar 2015	10-Q	09 May 2016	2016	Q1
Q3 2014	34,859,000	+33,064,000	+1842%	01 Jul 2014	30 Sep 2014	10-Q	05 Nov 2015	2015	Q3
Q1 2014	32,282,000			01 Jan 2014	31 Mar 2014	10-Q/A	28 Jul 2015	2015	Q1
Q3 2013	1,795,000			01 Jul 2013	30 Sep 2013	10-Q	12 Nov 2014	2014	Q3

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2022	121,037,000	+19,171,000	+19%	01 Jan 2022	31 Dec 2022	10-K	01 Mar 2023	2022	FY
2021	101,866,000	+27,681,000	+37%	01 Jan 2021	31 Dec 2021	10-K	01 Mar 2023	2022	FY
2020	74,185,000	+31,961,000	+76%	01 Jan 2020	31 Dec 2020	10-K	01 Mar 2023	2022	FY
2019	42,224,000	+5,136,000	+14%	01 Jan 2019	31 Dec 2019	10-K	24 Feb 2022	2021	FY
2018	37,088,000	+1,081,000	+3%	01 Jan 2018	31 Dec 2018	10-K	04 Mar 2021	2020	FY
2017	36,007,000	+521,000	+1.5%	01 Jan 2017	31 Dec 2017	10-K	27 Feb 2020	2019	FY
2016	35,486,000	+906,000	+2.6%	01 Jan 2016	31 Dec 2016	10-K	28 Feb 2019	2018	FY
2015	34,580,000			01 Jan 2015	31 Dec 2015	10-K	05 Mar 2018	2017	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.